You are here

  • Home
  • Archive
  • Volume 11, Issue 10
  • Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)

Article metrics

Article menu
Infectious diseases
Protocol
Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)

 

Online download statistics by month:

Online download statistics by month: October 2021 to April 2024

AbstractFullPdf
Oct 2021720715205
Nov 2021234223142
Dec 2021169175112
Jan 202212812638
Feb 202214213227
Mar 202214313331
Apr 2022746423
May 2022787037
Jun 2022433724
Jul 2022333113
Aug 2022393321
Sep 2022312715
Oct 2022433414
Nov 2022504223
Dec 2022252611
Jan 2023434113
Feb 2023242412
Mar 2023585414
Apr 2023161115
May 202319148
Jun 202316146
Jul 202322197
Aug 202318185
Sep 202314125
Oct 2023222114
Nov 202315146
Dec 202317136
Jan 202431195
Feb 202415139
Mar 2024131124
Apr 202410920
Total23052175905